Enzon Pharmaceuticals, Inc.Enzon Pharmaceuticals, Inc.Enzon Pharmaceuticals, Inc.

Enzon Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪5.97 M‬USD
‪1.37 M‬USD
‪66.17 M‬
Beta (1Y)
0.87

About Enzon Pharmaceuticals, Inc.

CEO
Richard L. Feinstein
Headquarters
Cranford
Website
Founded
1981
FIGI
BBG000BHYZB2
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ENZN is 0.0724 USD — it has increased by 11.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Enzon Pharmaceuticals, Inc. stocks are traded under the ticker ENZN.
Enzon Pharmaceuticals, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
ENZN stock is 10.45% volatile and has beta coefficient of 0.87. Check out the list of the most volatile stocks — is Enzon Pharmaceuticals, Inc. there?
Yes, you can track Enzon Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ENZN stock has fallen by 21.65% compared to the previous week, the month change is a 5.99% fall, over the last year Enzon Pharmaceuticals, Inc. has showed a 67.55% decrease.
ENZN net income for the last quarter is ‪672.00 K‬ USD, while the quarter before that showed ‪321.00 K‬ USD of net income which accounts for 109.35% change. Track more Enzon Pharmaceuticals, Inc. financial stats to get the full picture.
Today Enzon Pharmaceuticals, Inc. has the market capitalization of ‪5.57 M‬, it has increased by 35.43% over the last week.
Like other stocks, ENZN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enzon Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ENZN reached its all-time high on Nov 7, 2000 with the price of 84.1250 USD, and its all-time low was 0.0200 USD and was reached on Oct 1, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enzon Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enzon Pharmaceuticals, Inc. stock shows the sell signal. See more of Enzon Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.